QuidelOrtho Operating Margin 2010-2023 | QDEL
Current and historical operating margin for QuidelOrtho (QDEL) over the last 10 years. The current operating profit margin for QuidelOrtho as of December 31, 2023 is 9.22%.
| QuidelOrtho Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2023-12-31 | $3.00B | $0.14B | 4.64% |
| 2023-09-30 | $3.12B | $0.19B | 5.93% |
| 2023-06-30 | $3.16B | $0.22B | 6.83% |
| 2023-03-31 | $3.11B | $0.32B | 10.39% |
| 2022-12-31 | $3.27B | $0.84B | 25.85% |
| 2022-09-30 | $3.04B | $1.14B | 37.38% |
| 2022-06-30 | $2.76B | $1.36B | 49.24% |
| 2022-03-31 | $2.33B | $1.30B | 56.02% |
| 2021-12-31 | $1.70B | $0.91B | 53.33% |
| 2021-09-30 | $1.87B | $1.15B | 61.25% |
| 2021-06-30 | $1.84B | $1.17B | 63.80% |
| 2021-03-31 | $1.86B | $1.23B | 66.22% |
| 2020-12-31 | $1.66B | $1.06B | 63.84% |
| 2020-09-30 | $1.01B | $0.48B | 47.66% |
| 2020-06-30 | $0.66B | $0.19B | 29.31% |
| 2020-03-31 | $0.56B | $0.11B | 20.32% |
| 2019-12-31 | $0.53B | $0.09B | 17.42% |
| 2019-09-30 | $0.52B | $0.09B | 16.70% |
| 2019-06-30 | $0.51B | $0.08B | 16.21% |
| 2019-03-31 | $0.50B | $0.08B | 15.17% |
| 2018-12-31 | $0.52B | $0.10B | 18.39% |
| 2018-09-30 | $0.50B | $0.07B | 14.29% |
| 2018-06-30 | $0.44B | $0.05B | 11.87% |
| 2018-03-31 | $0.37B | $0.04B | 10.99% |
| 2017-12-31 | $0.28B | $0.01B | 3.24% |
| 2017-09-30 | $0.22B | $0.01B | 5.09% |
| 2017-06-30 | $0.21B | $0.02B | 7.48% |
| 2017-03-31 | $0.22B | $0.02B | 8.37% |
| 2016-12-31 | $0.19B | $-0.00B | -2.09% |
| 2016-09-30 | $0.19B | $-0.01B | -3.68% |
| 2016-06-30 | $0.19B | $-0.01B | -4.26% |
| 2016-03-31 | $0.18B | $-0.01B | -4.89% |
| 2015-12-31 | $0.20B | $0.00B | 1.53% |
| 2015-09-30 | $0.21B | $0.01B | 6.22% |
| 2015-06-30 | $0.20B | $0.00B | 0.99% |
| 2015-03-31 | $0.20B | $0.00B | 1.01% |
| 2014-12-31 | $0.18B | $-0.01B | -4.89% |
| 2014-09-30 | $0.17B | $-0.02B | -12.87% |
| 2014-06-30 | $0.16B | $-0.02B | -10.98% |
| 2014-03-31 | $0.16B | $-0.02B | -9.20% |
| 2013-12-31 | $0.18B | $0.00B | 2.25% |
| 2013-09-30 | $0.18B | $0.02B | 10.56% |
| 2013-06-30 | $0.18B | $0.02B | 13.41% |
| 2013-03-31 | $0.18B | $0.03B | 14.44% |
| 2012-12-31 | $0.16B | $0.01B | 5.77% |
| 2012-09-30 | $0.14B | $-0.00B | -2.86% |
| 2012-06-30 | $0.14B | $-0.00B | -2.86% |
| 2012-03-31 | $0.14B | $-0.00B | -2.92% |
| 2011-12-31 | $0.16B | $0.01B | 8.81% |
| 2011-09-30 | $0.15B | $0.01B | 7.19% |
| 2011-06-30 | $0.15B | $0.01B | 6.08% |
| 2011-03-31 | $0.15B | $0.01B | 4.14% |
| 2010-12-31 | $0.11B | $-0.02B | -14.16% |
| 2010-09-30 | $0.15B | $0.02B | 11.49% |
| 2010-06-30 | $0.18B | $0.04B | 25.00% |
| 2010-03-31 | $0.18B | $0.05B | 30.11% |
| 2009-12-31 | $0.17B | $0.05B | 31.52% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.712B | $2.998B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.877B | 24.14 |
| Stryker (SYK) | United States | $128.028B | 30.70 |
| Boston Scientific (BSX) | United States | $107.805B | 33.58 |
| Medtronic (MDT) | Ireland | $106.544B | 15.08 |
| EssilorLuxottica (ESLOY) | France | $97.060B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.204B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.949B | 30.46 |
| ResMed (RMD) | United States | $31.437B | 29.52 |
| Terumo (TRUMY) | Japan | $25.223B | 35.62 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.713B | 15.91 |
| Koninklijke Philips (PHG) | Netherlands | $24.656B | 19.10 |
| Baxter (BAX) | United States | $20.501B | 14.95 |
| Insulet (PODD) | United States | $12.040B | 63.21 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.549B | 0.00 |
| Demant (WILYY) | Denmark | $10.525B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.693B | 22.92 |
| BellRing Brands (BRBR) | United States | $7.226B | 38.85 |
| Haemonetics (HAE) | United States | $4.670B | 23.88 |
| Lantheus Holdings (LNTH) | United States | $4.561B | 11.78 |
| Perrigo (PRGO) | Ireland | $4.426B | 12.66 |
| GN Store Nord (GNNDY) | Denmark | $4.097B | 26.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.563B | 16.84 |
| Envista Holdings (NVST) | United States | $3.382B | 12.86 |
| Green Thumb Industries (GTBIF) | United States | $3.229B | 102.33 |
| Neogen (NEOG) | United States | $2.671B | 25.69 |
| ICU Medical (ICUI) | United States | $2.386B | 17.80 |
| Verano Holdings (VRNOF) | United States | $2.161B | 0.00 |
| TG Therapeutics (TGTX) | United States | $2.111B | 683.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.061B | 0.00 |
| Owens & Minor (OMI) | United States | $1.895B | 18.19 |
| Agios Pharmaceuticals (AGIO) | United States | $1.845B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.491B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.455B | 48.00 |
| InMode (INMD) | Israel | $1.444B | 7.47 |
| National Vision Holdings (EYE) | United States | $1.364B | 42.49 |
| AdaptHealth (AHCO) | United States | $1.309B | 9.85 |
| AtriCure (ATRC) | United States | $1.167B | 0.00 |
| Warby Parker (WRBY) | United States | $1.163B | 0.00 |
| MacroGenics (MGNX) | United States | $0.925B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.857B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.795B | 0.00 |
| Evolus (EOLS) | United States | $0.737B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.676B | 14.65 |
| VAREX IMAGING (VREX) | United States | $0.660B | 14.25 |
| TerrAscend (TSNDF) | Canada | $0.635B | 0.00 |
| Quanterix (QTRX) | United States | $0.617B | 0.00 |
| Jin Medical (ZJYL) | China | $0.591B | 0.00 |
| Valneva SE (VALN) | France | $0.519B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.503B | 0.00 |
| PetIQ (PETQ) | United States | $0.480B | 17.93 |
| ZimVie (ZIMV) | United States | $0.414B | 25.33 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.405B | 6.70 |
| Surmodics (SRDX) | United States | $0.366B | 39.52 |
| Zynex (ZYXI) | United States | $0.353B | 47.70 |
| Viemed Healthcare (VMD) | United States | $0.318B | 31.50 |
| Cerus (CERS) | United States | $0.309B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.263B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.249B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 14.71 |
| Organigram Holdings (OGI) | Canada | $0.219B | 0.00 |
| Veru (VERU) | United States | $0.198B | 0.00 |
| Omeros (OMER) | United States | $0.183B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.171B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.166B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.165B | 83.00 |
| Quipt Home Medical (QIPT) | United States | $0.153B | 0.00 |
| InterCure (INCR) | Israel | $0.133B | 22.46 |
| FitLife Brands (FTLF) | United States | $0.128B | 20.55 |
| MariMed (MRMD) | United States | $0.122B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 8.55 |
| Allurion Technologies (ALUR) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.087B | 0.00 |
| Chimerix (CMRX) | United States | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.075B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.062B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.053B | 3.47 |
| Apyx Medical (APYX) | United States | $0.050B | 0.00 |
| Bright Green (BGXX) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.66 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Flora Growth (FLGC) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.016B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |